Alexza Pharma (ALXA) – FDA
-
Alexza Pharma (ALXA) Reacquires ADASUVE Rights from Teva
-
Alexza Pharma (ALXA) Updates on AZ-002 Phase 2a in Epilepsy Patients; Dose-Related Decrease in Mean SPR Observed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ALXA Stock Lookup